“It’s important to acknowledge the size of the issue and enormity of the challenge. Approximately 880,000 Australians are now living with a severe and complex mental illness,” said Dirk Otto, the general manager of Boehringer Ingelheim Australia
Bondi Junction response must include increased funding and support for severe mental illness
October 11, 2024 Latest NewsBioPharmaLatest Video
New Stories
-
The industry faces significant uncertainty, with barely three weeks until the US election
October 14, 2024 - - Latest News -
TGA signs Memorandum of Understanding with South Africa's regulator
October 14, 2024 - - Latest News -
Dementia set to become Australia’s leading cause of death
October 13, 2024 - - Latest News -
Pharmac announces expanded access to three cancer medicines
October 11, 2024 - - Latest News -
Novartis-led partnership says heart health shouldn't be dependent on where you live
October 11, 2024 - - Latest News -
Bondi Junction response must include increased funding and support for severe mental illness
October 11, 2024 - - Latest News -
New report unveils hidden cost of Alzheimer’s disease, with cases to double by 2050
October 10, 2024 - - Latest News